HedgePath Pharmaceuticals, Inc. Intellectual Property Contracts & Agreements

6 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Exclusive License Agreement between Johns Hopkins University and Inhibitor Therapeutics, Inc.
License Agreements
HedgePath Pharmaceuticals, Inc.
Biotechnology
MD
2024
License Agreement Between Mayne Pharma Ventures Pty Ltd and Inhibitor Therapeutics, Inc. Regarding INTI Patents
License Agreements
HedgePath Pharmaceuticals, Inc.
Biotechnology
DE
2022
Sublicense Agreement between Mayne Pharma International Pty Ltd and Inhibitor Therapeutics, Inc. (August 2019)
License Agreements
HedgePath Pharmaceuticals, Inc.
Biotechnology
MD
2019
Amended and Restated Sublicense Agreement between Mayne Pharma International Pty Ltd and HedgePath Pharmaceuticals, Inc.
License Agreements
HedgePath Pharmaceuticals, Inc.
Biotechnology
MD
2019
Sublicense Agreement between Mayne Pharma International Pty Ltd and HedgePath Pharmaceuticals, Inc. (September 2, 2015)
License Agreements
HedgePath Pharmaceuticals, Inc.
Biotechnology
MD
2015
Patent License and Development Agreement between Commonwealth Biotechnologies, Inc. and Prism Pharmaceuticals, Inc.
License Agreements
HedgePath Pharmaceuticals, Inc.
Biotechnology
PA
2006